Publications by authors named "Jan Bosak"

Claim this Profile
E
Evaluation of adherence to abiraterone therapy in prostate cancer patients based on a population pharmacokinetic model.
Sara Merdita, Martin Šíma, Jan Dvořák, Martin Matějů, Igor Richter

Br J Clin Pharmacol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of immediate-release formulation with reliable absorption of rivaroxaban in various meal regimes.
Jan Bosák, Martin Šíma, Tereza Krejčí, Iva Obadalová, Jaroslava Šmardová

Clin Transl Sci· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Crushing tablets or sprinkling capsules: Implications for clinical strategy and study performance based on BE studies of rivaroxaban and deferasirox.
Jan Sus, Jan Bosak, Tomas Hauser

Clin Transl Sci· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The bioequivalence of fixed-dose combination tablets of bisoprolol and ramipril and its drug-drug interaction potential.
Jan Sus, Jade Huguet, Jan Bosak, Beatrice Setnik, Tomas Hauser

Clin Transl Sci· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validity of cycloheximide chylomicron flow blocking method for the evaluation of lymphatic transport of drugs.
Pavel Ryšánek, Tomáš Grus, Peter Lukáč, Petr Kozlík, Tomáš Křížek

Br J Pharmacol· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical evaluation of new formulation concepts for abiraterone acetate bioavailability enhancement based on the inhibition of pH-induced precipitation.
Tereza Boleslavská, Svatopluk Světlík, Pavel Žvátora, Jan Bosák, Ondřej Dammer

Eur J Pharm Biopharm· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis